Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Indian Regulations Cap Drug Prices; Pharma Companies’ Profits Likely Impacted

Reuters: India caps prices of 108 more medicines; drugmakers to take hit
“India’s pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories, and Ranbaxy Laboratories Ltd…” (Siddiqui, 7/14).